Invitae Corporation (0JDB.L) LSE
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In USD
Address
1400 16th Street
San Francisco, CA 94103
United States of America (the)
Phone
415 374 7782
Website
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
1700
First IPO Date
January 29, 2018
| Name | Title | Pay | Year Born |
| Kenneth D. Knight | President, Chief Executive Officer & Director | 1.4M | 1961 |
| Randal W. Scott | Co-Founder & Chairman of the Board | 50,000 | 1958 |
| Shelly D. Guyer | Chief Sustainability Officer | 430,444 | 1960 |
| W. Michael Korn | Chief Medical Officer | 751,951 | N/A |
| Thomas R. Brida | General Counsel, Chief Compliance Officer & Secretary | 776,722 | 1971 |
| David Sholehvar | Chief Operating Officer | 0 | 1968 |
| Ana J. Schrank | Chief Accounting Officer & Chief Financial Officer | 0 | 1966 |
| Desarie French | Chief Talent Officer | 0 | N/A |
| Hoki Luk | Head of Investor Relations and Capital Markets & Corporate Development | 0 | 1976 |
| Robert Guigley | Chief Commercial Officer | 0 | N/A |
Invitae Corporation is a medical genetics enterprise focused on integrating genetic insights into mainstream healthcare to improve patient outcomes across the United States, Canada, and internationally. The company delivers an extensive suite of genetic tests covering diverse clinical domains, including inherited cancers, cardiac health, neurological disorders, pediatric conditions, general oncology, metabolic diseases, and rare illnesses. Beyond testing, they also offer digital health platforms and health data services. Invitae serves a broad customer base, including individual patients, healthcare providers, biopharmaceutical companies, and other collaborators. Established in 2010 as Locus Development, Inc., the company adopted the name Invitae Corporation in 2012 and is headquartered in San Francisco, California.